EpiGentek Announces that it has been Selected as the 2019 Bioz Stars Award Winner in the Epigenetics Category Published 12/17/2019 |
|||
![]() |
|||
FARMINGDALE, N.Y., December 16, 2019-EpiGentek, a NY-based biotechnology firm specializing in epigenetic research products and services, is proud to announce that it has been awarded the Bioz Rising Star™ award for 2019. This prestigious award recognizes the world's most innovative suppliers of life science reagents, kits, instruments and tools for being leaders in their specific research category. As a leader in epigenetic technologies, EpiGentek’s products were able to edge out over 300 million products from 50,000 other suppliers listed on Bioz.com. "Bioz AI algorithms select a Bioz Stars Award winner in each life science product category. The algorithm applies weighting and normalization to a multitude of objective data-driven parameters, including the number of product mentions, article recency, journal impact factor, and product usage trends," said Daniel Levitt, CEO & Founder of Bioz. "It’s an honor to see that our products are trending in publications, which really validates the quality and robustness of our products," said William Lee, VP of Operations at EpiGentek. “Receiving Bioz’s recognition is greatly rewarding for our employees’ efforts and commitment to empower our customers’ research.” EpiGentek affirms that epigenetics research is on the rise, with particular growing interest in epitranscriptomics (specifically RNA methylation) as well as new chromatin analysis methods. The company continues to focus on its core specialty of epigenetics in order to develop and refine technologies that will yield researchers with the highest quality antibodies, kits and reagents.
About Bioz About EpiGentek Group Inc. |
|||
![]() |
|||
Terms & Conditions | Privacy Policy | Site Map |
| Copyright © EpiGentek Group Inc. All rights reserved. |